Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Cambrex Corporation. (CBM)

-NYSE
21.04 Up 0.08(0.38%) Apr 17, 4:03PM EDT
|After Hours : 20.94 Down 0.10 (0.45%) Apr 17, 5:53PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Cambrex Corporation.
One Meadowlands Plaza
East Rutherford, NJ 07073
United States - Map
Phone: 201-804-3000
Fax: 201-804-9852
Website: http://www.cambrex.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:936

Business Summary 

Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products consist of active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as other fine chemicals. The company serves generic drug companies, and companies that discover and commercialize new small molecule human therapeutics using organic chemistry. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Cambrex Corporation.

Corporate Governance 
Cambrex Corporation.’s ISS Governance QuickScore as of Apr 1, 2014 is 2. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 1; Compensation: 7.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Steven M. Klosk , 57
Chief Exec. Officer, Pres and Director
1.35M43.00K
Mr. Gregory P. Sargen , 48
Chief Financial Officer, Principal Accounting Officer and Exec. VP
999.00K283.00K
Mr. Shawn P. Cavanagh , 48
Chief Operating Officer and Exec. VP
1.04M0.00
Dr. Aldo G. Magnini , 61
Managing Director of Cambrex Profarmaco Milano
874.00K0.00
Mr. William M. Haskel , 52
Chief Compliance Officer, Sr. VP, Gen. Counsel and Corp. Sec.
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders